Posted on 12/6/19
Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable
In the middle of November, Editas Medicine (NASDAQ:EDIT) and Celgene (NASDAQ:CELG) announced changes to a development pact originally formed in 2015 with Juno Therapeutics, which is . . .
Posted on 12/6/19
IVERIC bio Announces Proposed Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE) announced that it is commencing an underwritten public offering of shares of its common stock (or pre-funded warrants to . . .
Posted on 12/6/19
Bayer Enters into Collaboration with Children's Hospital of Philadelphia
Bayer announced today that it has entered into a three-year collaboration agreement with Children's Hospital of Philadelphia (CHOP) for the discovery and development of small molecules . . .
Posted on 12/5/19
Zionexa Has Signed an Exclusive Agreement With PETNET Solutions for Manufacturing and Distribution
NEW YORK & PARIS--(BUSINESS WIRE)--Zionexa, a radiopharmaceutical company specialized in the development and commercialization of in-vivo biomarkers for use in guiding targeted therapies in oncology, and . . .
Posted on 12/5/19
Harvard Pilgrim Health Care And Ride Health Collaborate
Harvard Pilgrim Health Care and Ride Health have announced a collaboration to offer non-emergency medical transportation at no cost for Medicare Advantage members in Massachusetts and . . .
Posted on 12/5/19
Better Buy: Amgen vs. Pfizer
Amgen (NASDAQ:AMGN) and Pfizer (NYSE:PFE) have both proven to be outstanding income, value, and growth plays over the last decade. However, the next decade could be . . .
Posted on 12/5/19
Dow Jones News: Johnson & Johnson Concludes Asbestos Investigation; Analyst Sees Upside for United Technologies
The Dow Jones Industrial Average (DJINDICES:^DJI) rebounded on Wednesday, up 0.63% at 12:25 p.m. EST. A report from Bloomberg, which suggested that the U.S. and China . . .
Posted on 12/4/19
FINN Partners Health Practice Continues To Expand Global Reach
Global marketing and communications firm FINN Partners has added Medical & Health Consulting (MHC), a highly regarded Paris-based independent health and biopharma consultancy, to its international . . .
Posted on 12/4/19
Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors
Merck (NYSE:MRK) has performed well on the stock market this year. Since early January, the company's shares are up by about 15%, which compares favorably to . . .
Posted on 12/4/19
AGS Health Recognized as One of India's Best Workplaces by the Great Place to Work Institute-India
AGS Health, a global leader in revenue cycle management services for leading healthcare providers across the U.S. has been recognized among 'India's Best Workplaces in IT . . .
Posted on 12/4/19
Relmada Therapeutics Announces Proposed Public Offering of Common Stock
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced its intention to offer . . .
Posted on 12/3/19
Intec Pharma Announces $10 Million Ordinary Shares Purchase Agreement With Aspire Capital
Intec Pharma Ltd. (NASDAQ: NTEC) today announces that the Company has entered into an Ordinary Shares Purchase Agreement for $10.0 million with Aspire Capital Fund, LLC, . . .
Posted on 12/3/19
Celmatix Expands Strategic Partnership with Evotec in Women’s Health
NEW YORK--(BUSINESS WIRE)--Celmatix Inc., the leading precision health company advancing the fields of reproductive medicine and fertility at the intersection of big data and genomics, today . . .
Posted on 12/3/19
White Oak Healthcare Finance Closes Senior Credit Facility for Linden-Backed Virtus Pharmaceuticals
NEW YORK--(BUSINESS WIRE)--White Oak Healthcare Finance, LLC announced today that it acted as sole lender and administrative agent on a senior credit facility for Virtus Pharmaceuticals, a . . .
Posted on 12/3/19
Oyster Point Pharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights
PRINCETON, N.J., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of . . .
Posted on 12/3/19
3 Biotech Stocks With a Lot to Prove at ASH 2019
It's nearly time for the annual get-together of the American Society of Hematology (ASH). There will be presentations from too many drugmakers for any one person . . .
Posted on 12/3/19
Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen
Swiss drugmaker Novartis's (NYSE:NVS) $9.7 billion takeover of The Medicines Company (NASDAQ:MDCO) gives the former ownership of an investigational cardiovascular drug called inclisiran. And that may . . .
Posted on 12/3/19
New Jersey Urology Partners with Urology Care Alliance
New Jersey Urology, the leading urology service provider in New Jersey, and Urology Management Associates ("UMA") are pleased to announce a partnership with Urology Care Alliance, . . .
Posted on 12/2/19
Hyperfine and Penn Medicine Announce Partnership to Image Hydrocephalus Patients
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine Research Inc. has joined with Penn Medicine in a clinical research study of the world’s first portable, low-cost magnetic resonance imaging (MRI) system. . . .
Posted on 12/2/19
Better Buy: Abbott Laboratories vs. Johnson & Johnson
Healthcare giants. Blue chip stocks. Long-time winners for investors. All of these are true for both Abbott Laboratories (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ).In recent years, . . .
Posted on 11/27/19
Pfizer: Grab The Popcorn, Wait And See
SummaryPfizer has been losing patent protection of its star drugs and hence sales have been falling.The company is shifting its focus to oncology and getting rid . . .
Posted on 11/27/19
Novartis' Latest Acquisition Of The Medicines Company Sets It Up For A Large Market
Summary Novartis announced that it would acquire The Medicines Company for $9.7 billion or for $85 per share, which was a 25% premium from Friday's close. . . .
Posted on 11/27/19
Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy
Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, . . .
Posted on 11/27/19
Arrow Physical Therapy And Rehabilitation Announces New Clinic In Springfield, New Jersey
Arrow Physical Therapy and Rehabilitation, an Alliance Physical Therapy Partner, is pleased to announce the opening of their new outpatient rehabilitation clinic in Springfield, NJ. The . . .
Posted on 11/26/19
Zelis Earns Great Place to Work Certification
BEDMINSTER, N.J.--(BUSINESS WIRE)--Zelis, a healthcare and financial technology growth company and market-leading provider of claims cost and payments optimization solutions to price, pay and explain healthcare . . .
New York
